Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

'base':45 'cancer':29 'cardiovascular':27 'chronic':24 'clinic':78 'compound':6,52 'develop':3,35,49,60 'diseas':18,21,26,28 'disord':23,46 'field':74 'gene':55 'genet':22 'infect':32 'inform':71 'investig':62 'liver':25,44 'liver-bas':43 'medic':64,67 'name':19 'oligonucleotid':5,51 'pharmaceut':11,37,76 'prepar':38 'provid':66 'purpos':65 'rare':20 'research':1,33,47,58,70 'scientif':57,61,69 'silenc':56 'target':10,54 'therapi':12 'treatment':15,41 'trial':79 'use':8 'various':17 'viral':31

DICERNA

Owners

Goods & Services